Analysis of factors associated with low peripheral blood progenitor cell collection in normal donors

被引:79
作者
de la Rubia, J [1 ]
Arbona, C [1 ]
de Arriba, F [1 ]
del Cañizo, C [1 ]
Brunet, S [1 ]
Zamora, C [1 ]
Díaz, MA [1 ]
Bargay, J [1 ]
Petit, J [1 ]
de la Serna, J [1 ]
Insunza, A [1 ]
Arrieta, R [1 ]
Pascual, MJ [1 ]
Serrano, D [1 ]
Sanjuan, I [1 ]
Espigado, I [1 ]
Alegre, A [1 ]
Martínez, D [1 ]
Verdeguer, A [1 ]
Martínez, C [1 ]
Benlloch, L [1 ]
Sanz, MA [1 ]
机构
[1] Hosp Univ La Fe, Serv Hematol, Valencia 46009, Spain
关键词
D O I
10.1046/j.1537-2995.2002.00010.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: Predictive factors of the response to rHuG-CSF in normal donors have not been extensively studied. STUDY DESIGN AND METHODS: We analyzed factors influencing CD34+ cell yield in the 1st day of collection in 261 healthy donors from the Spanish National Donor Registry. The median age was 38 years (range, 2-72). The median dose of rHuG-CSF was 10 mug per kg per day (range, 5-20) over 4 days. In 103 donors (40%), <4 x 106 per kg CD34+ cells were collected. The variables that were analyzed included age, sex, weight, basal complete blood cell count, dose, type of rHuGCSF and schedule of administration, and maximum WBC count before apheresis. RESULTS: By univarlate analysis, the maximum WBC count (<50 vs. greater than or equal to50 x 10(9)/L, p = 0.004), advanced age (p = 0.008), and number of daily rHuG-CSF doses (one vs. two; p = 0.01) correlated with the number of CD34+ cells collected. By multivariate analysis, donors age (<38 vs. 38 years; p = 0.014) and a single daily dose of rHuG-CSF (p = 0.005) were the two variables that significantly predicted a low CD34+ cell yield. CONCLUSION: Donors' age, with a threshold of 38 years or more, and the rHuG-CSF schedule are the factors that significantly affected CD34+ cell mobilization and collection in healthy donors.
引用
收藏
页码:4 / 9
页数:6
相关论文
共 31 条
[1]   Collection of peripheral blood stem cells from normal donors 60 years of age or older [J].
Anderlini, P ;
Przepiorka, D ;
Lauppe, J ;
Seong, D ;
Giralt, S ;
Champlin, R ;
Korbling, M .
BRITISH JOURNAL OF HAEMATOLOGY, 1997, 97 (02) :485-487
[2]   A comparative study of once-daily versus twice-daily filgrastim administration for the mobilization and collection of CD34+ peripheral blood progenitor cells in normal donors [J].
Anderlini, P ;
Donato, M ;
Lauppe, MJ ;
Huh, YO ;
Martin, TG ;
Chan, KW ;
Champlin, PE ;
Körbling, M .
BRITISH JOURNAL OF HAEMATOLOGY, 2000, 109 (04) :770-772
[3]   Factors affecting mobilization of CD34+ cells in normal donors treated with filgrastim [J].
Anderlini, P ;
Przepiorka, D ;
Seong, C ;
Smith, TL ;
Huh, YO ;
Lauppe, J ;
Champlin, R ;
Korbling, M .
TRANSFUSION, 1997, 37 (05) :507-512
[4]   Allogeneic blood progenitor cell collection in normal donors after mobilization with filgrastim:: the M.D. Anderson Cancer Center experience [J].
Anderlini, P ;
Donato, M ;
Chan, KW ;
Huh, YO ;
Gee, AP ;
Lauppe, MJ ;
Champlin, RE ;
Körbling, M .
TRANSFUSION, 1999, 39 (06) :555-560
[5]   Comparison between once a day vs twice a day G-CSF for mobilization of peripheral blood progenitor cells (PBPC) in normal donors for allogeneic PBPC transplantation [J].
Arbona, C ;
Prosper, F ;
Benet, I ;
Mena, F ;
Solano, C ;
Garcia-Conde, J .
BONE MARROW TRANSPLANTATION, 1998, 22 (01) :39-45
[6]   Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers. [J].
Bensinger, WI ;
Martin, PJ ;
Storer, B ;
Clift, R ;
Forman, SJ ;
Negrin, R ;
Kashyap, A ;
Flowers, MED ;
Lilleby, K ;
Chauncey, TR ;
Storb, R ;
Appelbaum, FR ;
Rowley, S ;
Heimfeld, S ;
Blume, K .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (03) :175-181
[7]   Randomized trial of bone marrow versus lenograstim-primed blood cell allogeneic transplantation in patients with early-stage leukemia: A report from the Societe Francaise de Greffe de Moelle [J].
Blaise, D ;
Kuentz, M ;
Fortanier, C ;
Bourhis, JH ;
Milpied, N ;
Sutton, L ;
Jouet, JP ;
Attal, M ;
Bordigoni, P ;
Cahn, JY ;
Boiron, JM ;
Schuller, MP ;
Moatti, JP ;
Michalle, M .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (03) :537-546
[8]   CD34+cell mobilization for allogeneic progenitor cell transplantation: efficacy of a short course of G-CSF [J].
de Fabritiis, P ;
Iori, AP ;
Mengarelli, A ;
Gozzer, M ;
Ferrazza, G ;
De Propris, MS ;
Romano, A ;
Arcese, W .
TRANSFUSION, 2001, 41 (02) :190-195
[9]   Administration of recombinant human granulocyte colony-stimulating factor to normal donors:: results of the Spanish National Donor Registry [J].
de la Rubia, J ;
Martínez, C ;
Solano, C ;
Brunet, S ;
Cascón, P ;
Arrieta, R ;
Alegre, A ;
Bargay, J ;
de Arriba, F ;
Cañizo, C ;
López, J ;
Serrano, D ;
Verdeguer, A ;
Torrabadella, M ;
Díaz, MA ;
Insunza, A ;
de la Serna, J ;
Espigado, I ;
Petit, J ;
Martínez, M ;
Benlloch, L ;
Sanz, MA .
BONE MARROW TRANSPLANTATION, 1999, 24 (07) :723-728
[10]   Donor age-related differences in PBPC mobilization with rHuG-CSF [J].
de la Rubia, J ;
Díaz, MA ;
Verdeguer, A ;
Pascual, MJ ;
Arbona, C ;
Arrieta, R ;
Brunet, S ;
Bargay, J ;
Martínez, C ;
Espigado, I ;
Serrano, D ;
Alegre, A ;
de Arriba, F ;
de la Serna, J ;
Zamora, C ;
Benlloch, L ;
Sanz, MA .
TRANSFUSION, 2001, 41 (02) :201-205